• Home
• Careers
• Working at GSK
• Ulan

Ulan has already lost a brother. We can’t let him lose hope.

Ulan was the lucky one. Both he and his brother were among the 300 million people who contracted malaria last year. Unfortunately, Ulan's brother was also one of over a million who failed to recover. Ulan says he'd like to be a doctor when he grows up, so he can look after his family if they ever get sick again. At GlaxoSmithKline, we're doing all we can to make sure that he doesn't need to worry.

In the developing world, malaria is one of the three greatest threats to human life. It's also symptomatic of an even greater problem; the disease of poverty. That's why our highly respected R&D function has a dedicated Diseases of the Developing World (DDW) group that prioritises projects according to their socio-economic and public health benefits rather than commercial returns.

In keeping with our company-wide culture of collaboration, we bring our technological, development and project management expertise to a number of vital public/private partnerships that make the creation, manufacture and distribution of affordable treatments possible.

But as well as producing an important therapy for the treatment of malaria, our collaborative approach to R&D fuels drug development initiatives intended to tackle other priority diseases, such as HIV and TB which continue to threaten the lives of millions world-wide.

At GSK, our mission is to help people around the world lead longer, healthier and happier lives - none of which would be possible without the remarkable achievements of our industry-leading R&D teams.

GSK is proud to promote an open culture, encouraging people to be themselves and giving their ideas a chance to flourish.

GSK is an equal opportunity employer.

Back to top